文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

全国性输液短缺期间急诊科静脉输液使用减少及其运营影响

Reduced IV fluid use and operational effects among emergency department patients during a national shortage.
PubMed 文献 · Am J Emerg Med · 2026-09-26
一句话结论全国性静脉输液短缺期间,急诊离院患者输液比例从19.8%降至6.5%,多种高流量病种急诊停留时间延长6–31分钟,脓毒症和镰状细胞血管闭塞危象输液比例下降。

该研究为回顾性分析,纳入九家医院共182,487例急诊离院 encounter(短缺前96,045例,短缺后86,442例),比较全国静脉输液短缺前后急诊离院患者的输液使用与运营指标。主要结果为离院患者输液比例从19.8%降至6.5%(绝对差-13.2个百分点,95%CI -13.5至-12.9),前20位诊断类别输液 odds 均下降(OR 0.10–0.39)。多种高流量病种急诊停留时间延长6–31分钟,仅呼吸系统症状停留时间缩短14分钟(95%CI -19至-8);糖尿病并发症、酒精相关障碍和上呼吸道感染的72小时返诊显著增加。脓毒症和镰状细胞血管闭塞危象中输液比例下降,糖尿病酮症酸中毒中保持相似。

要点

  • 短缺期间急诊离院患者输液比例由19.8%降至6.5%(绝对差-13.2个百分点,95%CI -13.5至-12.9),前20位诊断类别输液OR为0.10–0.39。
  • 短缺期间多种高流量病种急诊停留时间延长6–31分钟,仅呼吸系统症状停留时间缩短14分钟(95%CI -19至-8)。
  • 糖尿病并发症、酒精相关障碍和上呼吸道感染的72小时返诊在短缺期间显著增加。
  • 高危病种中,糖尿病酮症酸中毒急诊输液比例与短缺前相似,脓毒症和镰状细胞血管闭塞危象的输液比例下降。
  • 作者结论提示未来供应冲击期间需采用更细致、按诊断分层的资源分配策略,尤其关注镰状细胞血管闭塞危象等输液比例明显下降的病种。

适用人群与场景

  • 九家医院区域卫生系统内急诊离院 encounter,比较全国静脉输液短缺前与短缺后两个时期。

诊断标准与关键阈值

  • 原文未提及诊断标准、评分界值或启动/停止阈值。

处置流程与药物剂量

  • 原文未提及具体处置流程或药物剂量方案。

红旗征与不能漏的情况

  • 糖尿病并发症、酒精相关障碍和上呼吸道感染在短缺期间72小时返诊显著增加。
  • 脓毒症和镰状细胞血管闭塞危象中急诊输液比例下降,镰状细胞血管闭塞危象下降被作者特别指出值得关注。

研究设计与关键结果

  • 研究类型:回顾性分析,九家医院,182,487例急诊离院 encounter(短缺前96,045例,短缺后86,442例)。
  • 主要终点:离院患者输液比例从19.8%降至6.5%(绝对差-13.2个百分点,95%CI -13.5至-12.9);前20位诊断类别输液OR范围0.10–0.39(如憩室炎OR 0.10,95%CI 0.06至0.15;头痛OR 0.13,95%CI 0.11至0.15)。
  • 次要终点:多种高流量病种急诊停留时间延长6–31分钟,呼吸系统症状停留时间缩短14分钟(95%CI -19至-8);糖尿病并发症、酒精相关障碍和上呼吸道感染72小时返诊显著增加;糖尿病酮症酸中毒输液比例相似,脓毒症和镰状细胞血管闭塞危象输液比例下降。

证据类型、等级与局限

  • 证据类型:回顾性观察性研究(短缺前后比较)。
  • 局限:原文未给出证据等级或推荐强度;设计为回顾性、基于九家医院区域卫生系统,原文未提及单中心、开放标签或样本量局限等具体描述。

对床旁实践的改变

  • 该研究提示全国性输液短缺可显著改变急诊离院患者的输液实践,临床团队需预期输液比例大幅下降及部分病种急诊停留时间延长。
  • 对糖尿病并发症、酒精相关障碍和上呼吸道感染患者,短缺期间72小时返诊增加,提示需加强离院后随访或返诊风险评估。
  • 对脓毒症和镰状细胞血管闭塞危象,短缺期间输液比例下降,作者呼吁按诊断分层的资源分配策略;原文未提供具体替代方案或阈值。

指南或共识出处

  • 原文未提及指南或共识出处;来源类型为 pubmed(Am J Emerg Med)。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Intravenous (IV) fluids are an essential therapeutic in emergency care, frequently administered for a wide range of acute conditions. In September 2024, Hurricane Helene forced the closure of a major U.S. IV fluid manufacturing facility, triggering a nationwide shortage. While many health systems rapidly implemented conservation strategies, the downstream operational and clinical effects of reduced IV fluid allocations on emergency department (ED) care remain unknown.

METHODS: We conducted a retrospective analysis of discharged ED encounters from nine hospitals within a regional health system, comparing pre- and post-shortage periods. The primary outcomes were the proportion of discharged patients receiving IV fluids and ED length of stay (LOS). Secondary outcomes included 72-h return ED visits, and the proportion of encounters receiving IV fluids among prespecified high-risk conditions (sepsis, diabetic ketoacidosis (DKA), and sickle cell vaso-occlusive crisis).

RESULTS: 182,487 ED discharge encounters (96,045 pre and 86,442 post intervention) across nine sites were included. The proportion of discharged patients receiving IV fluids fell from 19.8% to 6.5% (absolute difference -13.2 percentage points, 95% CI -13.5 to -12.9). Odds of receiving IV fluids decreased across all top 20 diagnostic categories (OR range 0.10-0.39; e.g. diverticulitis OR 0.10 95% CI [0.06, -0.15], headache 0.13, [0.11,0.15]). The IV fluid shortage was associated with an increased ED LOS for many high-volume conditions (range 6 to 31 min) while only respiratory symptoms had a significantly decreased LOS (-14 min, 95% CI -19, -8). Significant increases in 72-h return visits occurred for diabetes complications, alcohol-related disorders, and upper respiratory infections. Among high-risk conditions, the proportion of all ED encounters receiving IV fluids was similar in diabetic ketoacidosis but declined in sepsis and sickle cell vaso-occlusive crisis.

CONCLUSION: The 2024 IV fluid shortage was associated with substantial changes in ED treatment patterns for discharged patients, with reduced fluid use and variable impacts on LOS across conditions. While care for some high-risk diagnoses remained stable, others, such as sickle cell vaso-occlusive crisis, experienced notable declines, underscoring the need for more nuanced and diagnosis-specific resource allocation strategies during future supply shocks.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Blenden M, Sangal RB, Rothenberg C, et al. Reduced IV fluid use and operational effects among emergency department patients during a national shortage. Am J Emerg Med. 2026. PMID: 42826624. doi:10.1016/j.ajem.2026.09.042

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。